Difference between revisions of "RAD53 / YPL153C Week 3"

From LMU BioDB 2019
Jump to navigation Jump to search
(Acknowledgments: Added description to acknowledgements on previous page)
(signed acknowledgments)
Line 110: Line 110:
  
 
[[User:Ntesfaio|Ntesfaio]] ([[User talk:Ntesfaio|talk]]) 16:34, 16 September 2019 (PDT)
 
[[User:Ntesfaio|Ntesfaio]] ([[User talk:Ntesfaio|talk]]) 16:34, 16 September 2019 (PDT)
 +
 +
"Except for what is noted above, this individual journal entry was completed by me and not copied from another source."
 +
[[User:Cdomin12|Cdomin12]] ([[User talk:Cdomin12|talk]]) 15:47, 17 September 2019 (PDT)
  
 
===References===  
 
===References===  

Revision as of 15:47, 17 September 2019

My Favorite Gene

Christina Dominguez and Naomi Tesfaiohannes

Summary of RAD53/ YPL153C:

RAD53 is a DNA damage response. It is required for cell cycle arrest. Its signal transduction pathway component is required for DNA damage and replication.

The summary should be one paragraph about the function of your gene based on what you have read in each of the four databases. This is one paragraph that synthesizes information, not one paragraph per database.

1. Standard name, systematic name, and name description for your gene (from SGD)?

Standard Name: Rad53

Systematic Name: YPL153C

Name Description: RADiation sensitive

It is a DNA damage response kinase and plays a role in the initiation of DNA replication.

2. Gene ID (identifier) for your gene in all four databases (SGD, NCBI Gene, Ensembl, UniProt)?

Gene ID in SGD: S000006074

Gene ID in NCBI: S000006074

Gene ID in Ensembl: S000006074

Gene ID in UniProt: S000006074

All 4 databases use the same Gene ID

3. DNA sequence of your gene?

ATGGAAAATATTACACAACCCACACAGCAATCCACGCAGGCTACTCAAAGGTTTTTGATT GAGAAGTTTTCTCAAGAACAGATCGGCGAAAACATTGTGTGCAGGGTCATTTGTACCACG GGTCAAATTCCCATCCGAGATTTGTCAGCTGATATTTCACAAGTGCTTAAGGAAAAACGA TCCATAAAGAAAGTTTGGACATTTGGTAGAAACCCAGCCTGTGACTATCATTTAGGAAAC ATTTCAAGACTGTCAAATAAGCATTTCCAAATACTACTAGGAGAAGACGGTAACCTTTTA TTGAATGACATTTCCACTAATGGGACCTGGTTAAATGGGCAAAAAGTCGAGAAGAACAGC AATCAGTTACTGTCTCAAGGTGATGAAATAACCGTTGGTGTAGGCGTGGAATCAGATATT TTATCTCTGGTCATTTTCATAAACGACAAATTTAAGCAGTGCCTCGAGCAGAACAAAGTT GATCGCATAAGATCTAACCTGAAAAATACCTCTAAAATAGCTTCTCCTGGTCTTACATCA TCTACTGCATCATCAATGGTGGCCAACAAGACTGGTATTTTTAAGGATTTTTCGATTATT GACGAAGTGGTGGGCCAGGGTGCATTTGCCACAGTAAAGAAAGCCATTGAAAGAACTACT GGGAAAACATTCGCGGTGAAGATTATAAGTAAACGCAAAGTAATAGGCAATATGGATGGT GTGACAAGAGAGTTAGAAGTATTGCAAAAGCTCAATCATCCAAGGATAGTACGATTGAAA GGATTTTATGAAGATACTGAGAGTTATTATATGGTGATGGAGTTCGTTTCTGGTGGTGAC TTAATGGATTTTGTTGCTGCTCATGGTGCGGTTGGAGAAGATGCTGGGAGGGAGATATCC AGGCAGATACTCACAGCAATAAAATACATTCACTCTATGGGCATCAGCCATCGTGACCTA AAGCCCGATAATATTCTTATTGAACAAGACGATCCTGTATTGGTAAAGATAACCGACTTT GGTCTGGCAAAAGTACAAGGAAATGGGTCTTTTATGAAAACCTTCTGTGGCACTTTGGCA TATGTGGCACCTGAAGTCATCAGAGGTAAAGATACATCCGTATCTCCTGATGAATACGAA GAAAGGAATGAGTACTCTTCGTTAGTGGATATGTGGTCAATGGGATGTCTTGTGTATGTT ATCCTAACGGGCCACTTACCTTTTAGTGGTAGCACACAGGACCAATTATATAAACAGATT GGAAGAGGCTCATATCATGAAGGGCCCCTCAAAGATTTCCGGATATCTGAAGAAGCAAGA GATTTCATAGATTCATTGTTACAGGTGGATCCAAATAATAGGTCGACAGCTGCAAAAGCC TTGAATCATCCCTGGATCAAGATGAGTCCATTGGGCTCACAATCATATGGTGATTTTTCA CAAATATCCTTATCACAATCGTTGTCGCAGCAGAAATTATTAGAAAATATGGACGATGCT CAATACGAATTTGTCAAAGCGCAAAGGAAATTACAAATGGAGCAACAACTTCAAGAACAG GATCAGGAAGACCAAGATGGAAAAATTCAAGGATTTAAAATACCCGCACACGCCCCTATT CGATATACACAGCCCAAAAGCATTGAAGCAGAAACTAGAGAACAAAAACTTTTACATTCC AATAATACTGAGAATGTCAAGAGCTCAAAGAAAAAGGGTAATGGTAGGTTTTTAACTTTA AAACCATTGCCTGACAGCATTATTCAAGAAAGCCTGGAGATTCAGCAAGGTGTGAATCCA TTTTTCATTGGTAGATCCGAGGATTGCAATTGTAAAATTGAAGACAATAGGTTGTCTCGA GTTCATTGCTTCATTTTCAAAAAGAGGCATGCTGTAGGCAAAAGCATGTATGAATCTCCG GCACAAGGTTTAGATGATATTTGGTATTGCCACACCGGAACTAACGTGAGCTATTTAAAT AATAACCGCATGATACAGGGTACGAAATTCCTTTTACAAGACGGAGATGAAATCAAGATC ATTTGGGATAAAAACAATAAATTTGTCATTGGCTTTAAAGTGGAAATTAACGATACTACA GGTCTGTTTAACGAGGGATTAGGTATGTTACAAGAACAAAGAGTAGTACTTAAGCAAACA GCCGAAGAAAAAGATTTGGTGAAAAAGTTAACCCAGATGATGGCAGCTCAACGTGCAAAT CAACCCTCGGCTTCTTCTTCATCAATGTCGGCTAAGAAGCCGCCAGTTAGCGATACAAAT AATAACGGCAATAATTCGGTACTAAACGACTTGGTAGAGTCACCGATTAATGCGAATACG GGGAACATTTTGAAGAGAATACATTCGGTAAGTTTATCGCAATCACAAATTGATCCTAGT AAGAAGGTTAAAAGGGCAAAATTGGACCAAACCTCAAAAGGCCCCGAGAATTTGCAATTT TCGTAA

4. Protein sequence corresponding to your gene?

Translation of the DNA sequence RAD53

Frame 1 5'3' encodes the entire protein sequence

https://web.expasy.org/translate/

5. Function of your gene?

RAD53 encodes for a protein kinase which is required for the cell cycle checkpoint. It amplifies the initial signals for proteins that recognize DNA damage. A loss in RAD53 can lead to defects in checkpoint activation.

6. What was different about the information provided about your gene in each of the parent databases?

Were there differences in content, the information or data itself?

Were there differences in presentation of the information?

7. Why did you choose your particular gene? i.e., why is it interesting to you and your partner?

8. Include an image related to your gene (be careful that you do not violate any copyright restrictions!)

Please make the image something scientific (not like the random images seen on the SGD blog posts). If a 3D structure of the protein your gene encodes is available, you can choose to embed a rotating image of the structure on your page using the FirstGlance in Jmol software. This is optional, a different static image would be OK, too.

Acknowledgments

For the beginning of this assignment, work was saved on the wiki page Cdomin12 and Ntesfaio Week 3. However, the name of the week 3 individual assignment was to be named after the gene. The proper name was then changed to RAD53 / YPL153C Week 3 and the syntax that was edited on the previous page was transferred over to this page. Previous saves can be seen in the "view history" tab of the page Cdomin12 and Ntesfaio Week 3.

Both partners should sign the Academic Honesty statement with their wiki signatures. You need to cite the specific database page from which you derived your information for each of the questions. When answering the free-form questions, be sure to paraphrase.


"Except for what is noted above, this individual journal entry was completed by me and not copied from another source."

Ntesfaio (talk) 16:34, 16 September 2019 (PDT)

"Except for what is noted above, this individual journal entry was completed by me and not copied from another source." Cdomin12 (talk) 15:47, 17 September 2019 (PDT)

References

Bio DB Home page

Template:Ntesfaio

Week 1

User:Ntesfaio

Class Journal Week 1

Week 2

Ntesfaio Week 2

Class Journal Week 2

Week 3

RAD53 / YPL153C Week 3

Class Journal Week 3


Week 4

Ntesfaio Week 4

Class Journal Week 4

Week 5

DrugCentral Week 5

Class Journal Week 5

Week 6

Ntesfaio Week 6

Class Journal Week 6

Week 7

Ntesfaio Week 7

Class Journal Week 7

Week 8

Ntesfaio Week 8

Class Journal Week 8

Week 9

Ntesfaio Week 9

Class Journal Week 9

Week 10

Ntesfaio Week 10

Week 11

Ntesfaio Week 11

Sulfiknights

Week 12/13

Ntesfaio Week 12/13

Sulfiknights

Sulfiknights Deliverables

Ntesfaio Week 15

Ntesfaio Final Individual Reflection

User Page

template: cdomin12

Assignment Page Individual Journal Entries Class Journal
Week 1 cdomin12 Week 1 Class Journal Week 1
Week 2 cdomin12 Week 2 Class Journal Week 2
Week 3 RAD53 / YPL153C Week 3 Class Journal Week 3
Week 4 cdomin12 Week 4 Class Journal Week 4
Week 5 IMG/VR Week 5 Class Journal Week 5
Week 6 cdomin12 Week 6 Class Journal Week 6
Week 7 cdomin12 Week 7 Class Journal Week 7
Week 8 cdomin12 Week 8 Class Journal Week 8
Week 9 cdomin12 Week 9 Class Journal Week 9
Week 10 cdomin12 Week 10 Class Journal Week 10
Week 11 cdomin12 Week 11 Skinny Genes
Week 12/13 Skinny Genes Quality Assurance Skinny Genes
Week 15 Skinny Genes Deliverables Skinny Genes